Argos Therapeutics Inc fka ARGSQ

[Schnauzer1]

Austin,

I would also note that were the company being considered as a target, and in conversations with a buyer, often its a precondition to purchase that the target do housecleaning with staffing numbers prior to the announcement. If anything the house cleaning provides greater support for the argument that ARGS is indeed a target for purchase. I have no information on this issue. Just saying if that were in the works!

Frankly, this P3 is looking good. When the 3rd interim review is completed by the Data Review Committee you should see a substantial rush up in the stock price. Assuming you wanted to get out early. And on passage of the P3 another multiple of 100% rise. I am long this one.